Early Recognition and Treatment of Hemophagocytic Lymphohistocytosis in A Child with the Early Symptom of DIC
Article Information
Wanqi Zheng, Yuchuan Wang, Zhengjuan Liu*, Xinbo Yu, Zhao Sun
Department of Pediatrics, The Second Affiliated Hospital of Dalian Medical University, Dalian, China
*Corresponding Author: Dr. Zhengjuan Liu, Department of Pediatrics, The Second Affiliated Hospital of Dalian Medical University, 467 Zhongshan Road, Shahekou District, Dalian 116027, China
Received: 25 March 2020; Accepted: 06 April 2020; Published: 05 May 2020
Citation: Wanqi Zheng, Yuchuan Wang, Zhengjuan Liu, Xinbo Yu, Zhao Sun. Early Recognition and Treatment of Hemophagocytic Lymphohistocytosis in A Child with the Early Symptom of DIC. Archives of Clinical and Medical Case Reports 4 (2020): 352-355.
View / Download Pdf Share at FacebookAbstract
Background: Hemophagocytic lymphohistocytosis (HLH) is a potentially fatal multiple organ inflammatory response syndrome that is characterized by proliferation of histiocytes and inflammatory factor storm. The disease progress varies fast and has a high death rate. Disseminated intravascular coagulation (DIC) is one of the leading causes of death in HLH. Here, we reported a child suffered from secondary HLH with the early symptom of DIC.
Case Description: A 2.5 year-old boy was hospitalized in our ward of the Second Affiliated Hospital of Dalian Medical University due to persistent high fever. The patient had the early manifestation of DIC, which was different from sepsis, and also had progressive pancytopenia, high serum ferritin level, hepatic dysfunction, hypertriglyceridemia, elevated soluble IL-2 receptor level, and hemophagocytosis in the bone marrow. With early treatment of HLH, the patient recovered rapidly without recurrence.
Conclusion: DIC can appear in the early phase of HLH, and also note that it should be distinguished with sepsis. Early diagnosis and reasonable therapy are very important to improve the prognosis of HLH.
Keywords
Hemophagocytic lymphohistocytosis; Disseminated intravascular coagulation; Children; Sepsis
Hemophagocytic lymphohistocytosis articles, Disseminated intravascular coagulation articles, Children articles, Sepsis articles
Hemophagocytic lymphohistocytosis articles Hemophagocytic lymphohistocytosis Research articles Hemophagocytic lymphohistocytosis review articles Hemophagocytic lymphohistocytosis PubMed articles Hemophagocytic lymphohistocytosis PubMed Central articles Hemophagocytic lymphohistocytosis 2023 articles Hemophagocytic lymphohistocytosis 2024 articles Hemophagocytic lymphohistocytosis Scopus articles Hemophagocytic lymphohistocytosis impact factor journals Hemophagocytic lymphohistocytosis Scopus journals Hemophagocytic lymphohistocytosis PubMed journals Hemophagocytic lymphohistocytosis medical journals Hemophagocytic lymphohistocytosis free journals Hemophagocytic lymphohistocytosis best journals Hemophagocytic lymphohistocytosis top journals Hemophagocytic lymphohistocytosis free medical journals Hemophagocytic lymphohistocytosis famous journals Hemophagocytic lymphohistocytosis Google Scholar indexed journals lymphohistocytosis articles lymphohistocytosis Research articles lymphohistocytosis review articles lymphohistocytosis PubMed articles lymphohistocytosis PubMed Central articles lymphohistocytosis 2023 articles lymphohistocytosis 2024 articles lymphohistocytosis Scopus articles lymphohistocytosis impact factor journals lymphohistocytosis Scopus journals lymphohistocytosis PubMed journals lymphohistocytosis medical journals lymphohistocytosis free journals lymphohistocytosis best journals lymphohistocytosis top journals lymphohistocytosis free medical journals lymphohistocytosis famous journals lymphohistocytosis Google Scholar indexed journals Disseminated intravascular coagulation articles Disseminated intravascular coagulation Research articles Disseminated intravascular coagulation review articles Disseminated intravascular coagulation PubMed articles Disseminated intravascular coagulation PubMed Central articles Disseminated intravascular coagulation 2023 articles Disseminated intravascular coagulation 2024 articles Disseminated intravascular coagulation Scopus articles Disseminated intravascular coagulation impact factor journals Disseminated intravascular coagulation Scopus journals Disseminated intravascular coagulation PubMed journals Disseminated intravascular coagulation medical journals Disseminated intravascular coagulation free journals Disseminated intravascular coagulation best journals Disseminated intravascular coagulation top journals Disseminated intravascular coagulation free medical journals Disseminated intravascular coagulation famous journals Disseminated intravascular coagulation Google Scholar indexed journals coagulation articles coagulation Research articles coagulation review articles coagulation PubMed articles coagulation PubMed Central articles coagulation 2023 articles coagulation 2024 articles coagulation Scopus articles coagulation impact factor journals coagulation Scopus journals coagulation PubMed journals coagulation medical journals coagulation free journals coagulation best journals coagulation top journals coagulation free medical journals coagulation famous journals coagulation Google Scholar indexed journals Children articles Children Research articles Children review articles Children PubMed articles Children PubMed Central articles Children 2023 articles Children 2024 articles Children Scopus articles Children impact factor journals Children Scopus journals Children PubMed journals Children medical journals Children free journals Children best journals Children top journals Children free medical journals Children famous journals Children Google Scholar indexed journals treatment articles treatment Research articles treatment review articles treatment PubMed articles treatment PubMed Central articles treatment 2023 articles treatment 2024 articles treatment Scopus articles treatment impact factor journals treatment Scopus journals treatment PubMed journals treatment medical journals treatment free journals treatment best journals treatment top journals treatment free medical journals treatment famous journals treatment Google Scholar indexed journals Sepsis articles Sepsis Research articles Sepsis review articles Sepsis PubMed articles Sepsis PubMed Central articles Sepsis 2023 articles Sepsis 2024 articles Sepsis Scopus articles Sepsis impact factor journals Sepsis Scopus journals Sepsis PubMed journals Sepsis medical journals Sepsis free journals Sepsis best journals Sepsis top journals Sepsis free medical journals Sepsis famous journals Sepsis Google Scholar indexed journals disease articles disease Research articles disease review articles disease PubMed articles disease PubMed Central articles disease 2023 articles disease 2024 articles disease Scopus articles disease impact factor journals disease Scopus journals disease PubMed journals disease medical journals disease free journals disease best journals disease top journals disease free medical journals disease famous journals disease Google Scholar indexed journals chemoembolization articles chemoembolization Research articles chemoembolization review articles chemoembolization PubMed articles chemoembolization PubMed Central articles chemoembolization 2023 articles chemoembolization 2024 articles chemoembolization Scopus articles chemoembolization impact factor journals chemoembolization Scopus journals chemoembolization PubMed journals chemoembolization medical journals chemoembolization free journals chemoembolization best journals chemoembolization top journals chemoembolization free medical journals chemoembolization famous journals chemoembolization Google Scholar indexed journals Surgery articles Surgery Research articles Surgery review articles Surgery PubMed articles Surgery PubMed Central articles Surgery 2023 articles Surgery 2024 articles Surgery Scopus articles Surgery impact factor journals Surgery Scopus journals Surgery PubMed journals Surgery medical journals Surgery free journals Surgery best journals Surgery top journals Surgery free medical journals Surgery famous journals Surgery Google Scholar indexed journals
Article Details
1. Introduction
Hemophagocytic lymphohistocytosis (HLH) is not a single disease, but rather a hyperinflammatory syndrome caused by excessive activation of lymphocytes and macrophages that produce high levels of cytokines. The main symptoms of HLH are prolonged high fever, hepatosplenomegaly, and cytopenias. Characteristic laboratory abnormalities include elevated ferritin, triglycerides, transaminases, lactate dehydrogenase (LDH) and low fibrinogen [1]. Here, we reported a child HLH with the early symptom of DIC and provided clinical experience for its early diagnosis and treatment.
2. Clinical Information
A 2.5 year-old boy was hospitalized in January 2020 due to persistent high fever 3 days. The highest body temperature was 40ºC. He was given oral azithromycin and oseltamivir for 2 days, but the effect was not satisfactory. Physical examination: T 38.6 ºC, P 136/min, R 26/min, Bp 92/61 mmHg, BW: 13.5 kg. He was conscious but tended to sleep. The pharyngeal mucous membrane was congested. The liver and spleen were not touched under the ribs. Endings of limbs were warm, and capillary filling time was normal. Laboratory testing on admission: Blood routine test: WBC 6.08 × 109/L, Neutrophil count 2.22 × 109/L, Hb 101 g/L, PLT 114 × 109/L, CRP 3.26 mg/L; DIC test: D-dimer 25.13 ug/ml, FDP > 150 ug/ml, PT 16.8 s, APTT 53.1 s, TT 24.6 s, Fbg 1.18 g/L. Pancytopenia and coagulation disorders were aggravated progressively while hospitalized (Table 1). Other laboratory examinations: Liver biochemistry: ALT 42.1 U/L, AST 289.5 U/L, LDH 1931.6 U/L, TB 30.4 umol/L; Myocardial enzyme: α-HBDH 1275.42 U/L, CK 489.69 U/L, CK-MB 53.08 U/L; Serum ferrintin (SF) > 1650.0 ng/mL; Soluble IL-2 receptor level: 1317.00 U/ml; Triglyceride (TG): 3.2 mmol/L; NK%: 9.2%; Bone marrow examination showed evidence of hemophagocytosis. The boy was diagnosed as HLH. Although the common pathogens such as epstein-barr virus (EBV) and cytomegalovirus (CMV) were negative during hospitalization, we considered he was secondary HLH because the gene variation about primary HLH had not been detected by genetic testing. The boy had a cefathiamidine for anti-infection and a nadroparin calcium as anticoagulant therapy. In order to inhibit inflammation reaction, he was given IVIG (500 mg/d) for 4 days, combined with a intravenous injection of dexamethasone (5 mg/d) for 6 days, and then changed to oral. The symptoms recovered gradually. Laboratory parameters returned to normal 10 days later. After being discharged, oral dexamethasone treatment was continued. The dosage was reduced by 50% every 2 weeks and discontinued at the end of 8 weeks. At the time of follow-up, the boy was fine without relapse.
Laboratory parameter |
Day 1 |
Day 2 |
Day 4 |
Day 6 |
Neutrophil count (× 109/L) |
2.22 |
1.62 |
0.95 |
1.22 |
Hemoglobin (g/L) |
101 |
96 |
88 |
101 |
Blood platelet count (× 109/L) |
114 |
105 |
61 |
236 |
D-dimer (ug/ml) |
25.13 |
Negative |
17.09 |
0.57 |
PT (s) |
16.8 |
Negative |
18 |
12.2 |
APTT (s) |
53.1 |
Negative |
35.3 |
31.7 |
TT (s) |
24.6 |
Negative |
34.2 |
19 |
Fibrinogen (g/L) |
1.18 |
Negative |
0.6 |
1.32 |
Table 1: The change in blood routine and coagulation function test.
3. Discussion
HLH is related to abnormal immune activation and inflammation. It can occur in people of all ages, however, early childhood is the high-risk period [2]. It is classified as genetic (primary) and acquired (secondary) forms of HLH due to different pathogenesis. Primary HLH (pHLH) is caused by genetic defects involved in cytotoxic granule exocytosis or function. Secondary HLH (sHLH) is related to infection, autoimmune diseases, malignant tumor, immunosuppression, metabolic diseasesand and even drugs [3-4]. The diagnostic criteria of HLH include fever, hepatosplenomegaly, hypocytosis, high serum ferritin level, decreased natural killer cell activity, elevated soluble IL-2 receptor level, hypertriglyceridemia or hypofibrinogenemia, and hemophagocytosis in the bone marrow, spleen, or lymph nodes. At least 5 of the 8 criteria above must be met for diagnosis [5-6]. In addition, elevated transaminase, LDH, bilirubin, low albumin, hyponatremia and abnormal symptoms of central nervous system (CNS) are considered as evidences supporting diagnosis [7].
This case is characterized by beginning with DIC as an early symptom. The severe abnormal DIC parameter had already appeared on admission, including the high level of D-dimer, FDP, prolonged APTT, PT and decreased fibrinogen. According to the International Society on Thrombosis and Haemostasis (ISTH) DIC scoring system [8], the score of this patient was 6 as DIC. Sepsis is one of the main reasons that can lead to DIC, and also has the similar characters with HLH, such as cytopenia, prolonged prothrombin time, activated partial thromboplastin time, hypofibrinogenemia, and elevated liver enzymes. Therefore it is important to distinguish HLH from sepsis for treatment. In this patient, DIC was an early symptom of HLH, whereas it often occurs in the terminal stage of sepsis, and always accompanied by multiple organ dysfunction syndrome (MODS).
Current guidelines recommend application of the HLH-94/2004 protocol, including use of etoposide, in patients with primary HLH and severe secondary HLH [9]. Corticosteroid and intravenous immunoglobulin (IVIG) can control the hyperactivated immune system, which are often selected for initial treatment [10]. Although the onset was acute and progress fast, our patient received good therapeutic effect with early combined treatment of dexamethasone and IVIG. So the early recognition and treatment may contribute to improve the prognosis of HLH.
In conclusion, DIC can be an initial symptom of HLH, which might be confused with sepsis. It is important for pediatricians to know the clinical characteristics of HLH for early treatment.
Conflict of Interest
Authors declare to have no conflict of interest.
References
- Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program 1 (2013): 605-611.
- Asano T, Kogawa K, Morimoto A, et al. Hemophagocytic lymphohistiocytosis after Hematopoietic stem cell transplantation in children: A nation wide survey in Japan. Pediatr Blood Cancer 59 (2012): 110-114.
- Sepulveda FE, de Saint Basile G. Hemophagocytic syndrome: primary forms and predisposing conditions. Curr Opin Immunol 49 (2017): 20-26.
- Strenger V, Merth G, Lackner H, et al. Malignancy and chemotherapy induced haemophagocytic lymphohistiocytosis in children and adolescents-a single centre experience of 20 years. Ann Hematol 97 (2018): 989-998.
- Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48 (2007): 124-131.
- Al-Samkari H, Berliner N. Hemophagocytic Lymphohistiocytosis. Annu Rev Pathol Mech Dis 13 (2018): 27-49.
- Trottestam H, Horne A, Arico M, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 118 (2011): 4577-4584.
- Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86 (2001): 1327-30.
- Zeng X, Wei N, Wang Y, et al. Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Zhonghua Xue ye Xue za Zhi 36 (2015): 507-510.
- Oguz MM, Sahin G, et al. Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single center experience and factors that influenced patient prognosis. Pediatr Hematol Oncol 36 (2019): 1-16.